DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras

Zhang, Xiaoyu, Luukkonen, Lena M., Eissler, Christie L., Crowley, Vincent M., Yamashita, Yu, Schafroth, Michael A., Kikuchi, Shota, Weinstein, David S. +11 more·2021·Journal of the American Chemical Society
DOI 10.1021/jacs.1c00990

Cited by (201)

Items 101–200 of 201

  1. Proteome‐Wide Ligand and Target Discovery by Using β ‐Nitrostyrene Electrophiles: Supporting Targeted Protein Degradation
    Xinyao Ouyang, Xiaomeng Chai, Lei Huang, Yubin Chen, Shengrong Li, Weizhen Huang, Yi-Fang Li, Ke Ding, Tongzheng Liu, Yi Tan et al. · 2025 · Angewandte Chemie International Edition
  2. Chemical Proteomics Identifies RBBP7 as a New E3 Ligase Supporting Targeted Protein Degradation
    Yue Liu, Tao Yang, Lei Huang, Shengrong Li, Tongzheng Liu, Yi Tan, Zhengqiu Li · 2025 · Angewandte Chemie International Edition
  3. Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
    Ines Forrest, Louis Patrick Conway, Clara Gathmann, Appaso Mahadev Jadhav, Tzu-Yuan Chiu, Christian M. Chaheine, Michelle A. Estrada, Anurupa Shrestha, Kathy Sarris, Justin M. Reitsma et al. · 2025 · ACS Central Science
  4. Nanomotor‐Driven Targeting Chimeras as Accelerators for the Degradation of Extracellular Proteins
    Yujun Ning, Bin Li, Yixin Liu, Yanwei Lu, Xuedong Huang, Baohong Liu · 2024 · Small
  5. SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
    Tingting Lv, Dongwei He, Xiaokuan Zhang, Xiaojin Guo, Zijie Li, Aili Zhang, Bo Fan, Zhiyu Wang · 2022 · Aging
  6. Rational Chemical Design of Molecular Glue Degraders
    Ethan S. Toriki, James W. Papatzimas, Kaila Nishikawa, Dustin Dovala, Lynn M. McGregor, Matthew J. Hesse, Jeffrey M. McKenna, John A. Tallarico, Markus Schirle, Daniel K. Nomura · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Comprehensive Mapping of Electrophilic Small Molecule-Protein Interactions in Human Cells
    Benjamin F. Cravatt, Evert Njomen, Rachel Hayward, Kristen E. DeMeester, Daisuke Ogasawara, Melissa M. Dix, Tracey Nguyen, Paige Ashby, Gabriel M. Simon, Stuart L. Schreiber et al. · 2023 · ChemRxiv
  8. Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds
    Ashley R. Julio, Flowreen Shikwana, Cindy C. Truong, Nikolas R. Burton, Emil R. Dominguez, Alexandra C. Turmon, Jian Xin Cao, Keriann M. Backus · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Rational discovery of molecular glue degraders based on block chemistry
    Junjie Wei, Wenjing Feng, Qingsong Chen, Qianbin Li, Zhuo Chen · 2025 · Drug Discovery Today
  10. PROTAC Degraders
    Alessio Ciulli, Oliver Hsia · 2022
  11. Targeted Protein Degradation through Recruitment of the CUL4A Complex Adaptor Protein DDB1
    Margot Meyers, Sabine Cismoski, Anoohya Panidapu, Barbara Chie-Leon, Daniel K. Nomura · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Azoacetylene Electrophiles for Proteome-wide Ligand and Target Discovery: Supporting Targeted Protein Degradation
    Jiayi Du, Shengrong Li, Fang Xu, Zehong Lin, Tongyi Hong, Yi-Fang Li, Zeyi Deng, Yi Tan, Zhengqiu Li · 2025 · Journal of Medicinal Chemistry
  13. The Role of Reactive Oxygen Species in Lung Cancer Development: Nanomedicine as a Therapeutic Strategy
    Manuel Olazábal-Morán, Elena Pérez, Adrián Esteban-Arranz, António Garrido · 2025 · Biomolecules
  14. Major Advances in Emerging Degrader Technologies
    Hang Luo, Li Wu, Yujian He, Chong Qin, Xinjing Tang · 2022 · Frontiers in Cell and Developmental Biology
  15. Conditional Covalent Lethality Driven by Oncometabolite Accumulation
    Minervo Perez, Kellie D. Nance, Daniel W. Bak, Supuni Thalalla Gamage, Susana Sarai Najera, Amy N. Conte, William Marston Linehan, Eranthie Weerapana, Jordan L. Meier · 2022 · ACS Chemical Biology
  16. Electrophilic Screening Platforms for Identifying Novel Covalent Ligands for E3 Ligases
    Sijin Zheng, Craig M. Crews · 2021 · Biochemistry
  17. Selection of DNA-encoded Chemical Libraries for Compounds that can Induce Protein Ubiquitination
    Cen Huang, Xing‐Yuan Liu, Xinyuan Wu, Ling Hua Meng, Xiaojie Lu, Xiaoyu Li · 2024 · ChemRxiv
  18. Exploiting the DCAF16–SPIN4 interaction to identify DCAF16 ligands for PROTAC development
    Isabella A. Riha, Miguel A. Lorenzo Campos, Xiao‐Kang Jin, Fiona Y. Wang, Chenlu Zhang, Sara F. Dunne, Benjamin F. Cravatt, Xiaoyu Zhang · 2024 · RSC Medicinal Chemistry
  19. The Expanding E3 Ligase-Ligand Landscape for PROTAC Technology
    Zhenzhen Li, Xiaoli Huang, Xuchi Zhao, Yunxiu Zhang, Ping Li · 2025 · Targets
  20. Dual E3 ligase recruitment by monovalent degraders for tunable SMARCA 2/4 degradation
    Valentina A. Spiteri, Dmitri Segal, Alejandro Correa-Sáez, Kentaro Iso, Ryan Casement, Miquel Muñoz i Ordoño, Mark A. Nakasone, Gajanan J. Sathe, Caroline Schätz, Hannah E. Peters et al. · 2026 · Nature Chemical Biology
  21. Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
    Adhikari, Bikash, Schneider, Katharina, Diebold, Mathias, Sotriffer, Christoph, Wolf, Elmar · 2024 · eLife
  22. A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation
    Ananya A. Basu, Chenlu Zhang, Isabella A. Riha, Assa Magassa, Felicia Ko, Xiaoyu Zhang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Novel mechanism for protein delivery in breast cancer therapy: A public health perspective
    Taiwo Temitope Ogunjobi, Ngozi Maryann Nebolisa, Rufus Oluwagbemileke Ajayi, Morenikeji Ibilola Euba, Adnan Musa, Abdul‐Hanan Saani Inusah, Femi Adedayo, Ojoisimi Franca Jamgbadi, Akinwunmi Rapheal Afuape, Adeleye Adegboyega Edema et al. · 2025 · European Journal of Sustainable Development Research
  24. Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches
    Qi Miao, Vilas D. Kadam, Ayan Mukherjee, Zhi Tan, Mingxing Teng · 2023 · Journal of Medicinal Chemistry
  25. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery
    Robert G. Guenette, Patrick Ryan Potts · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
  26. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy
    Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Shawn Chen, Sheng Wang · 2025 · Angewandte Chemie
  27. Expanding the druggable proteome strategies and innovations in targeted protein degradation
    Ke Ma, Ting Liu, Wen-Bo Huan, Ke-Zheng Chen, Sheng‐Lin Qiao · 2025 · Nano Today
  28. PROTACs in targeted protein degradation: Advances in development and AI-enhanced drug discovery
    Mao Du, Tao Liu, Wenyu Wang, Shuai Fan, Mei Tian, Qing Du, Zhidong Wang, Xiaodong Li, Xiaoyu Liu, Qin Xia et al. · 2026 · European Journal of Medicinal Chemistry Reports
  29. Ketoboronate as a Minimal Covalent-Reversible Tag for Targeted Lysosomal Degradation of Extracellular and Membrane Proteins
    Dany Pechalrieu, Véronique Nogueira, Nan Qiu, Brittney Racioppo, Daniel Abegg, Nissim Hay, Alexander Adibekian · 2025 · Journal of the American Chemical Society
  30. Covalent chemistry in targeted protein degradation
    Jing Tan, Yuxin Liang, Shiqun Shao, Youqing Shen · 2026 · Advanced Drug Delivery Reviews
  31. A pharmacological modality to sequester homomeric proteins
    Ella Livnah, Ohad Suss, Adi Rogel, Atar Gilat, Yuval Abdan, José A. Villegas, Ronen Gabizon, Almog Nadir, Yoav Shamir, Noam Y. Steinman et al. · 2026 · Nature Chemical Biology
  32. Discovery of a KLHL41 Ligand for Muscle Specific Protein Degradation
    Junhyeong Yim, Jaeseok Lee, Solbi Kim, Jieun Choi, Soyoung Yoon, Hana Cho, Sunbin Jung, GaYeon Yoo, Sanghee Lee, Hankum Park et al. · 2026 · Nature Communications
  33. Application of A lpha F old models in evaluating ligandable cysteines across E 3 ligases
    Patrick Koldenhof, Martijn P. Bemelmans, B.K. Ghosh, Kelly L. Damm‐Ganamet, Herman van Vlijmen, Vineet Pande · 2024 · Proteins Structure Function and Bioinformatics
  34. Harnessing the FBXW7 Somatic Mutant R465C for Targeted Protein Degradation
    Ananya A. Basu, Chenlu Zhang, Milad Rouhimoghadam, Anil Vasudevan, Justin M. Reitsma, Xiaoyu Zhang · 2025 · Journal of the American Chemical Society
  35. Covalent fragment screening
    Amit Shraga, Efrat Resnick, Ronen Gabizon, Nir London · 2021 · Annual reports in medicinal chemistry
  36. Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
    Adhikari, Bikash, Schneider, Katharina, Diebold, Mathias, Sotriffer, Christoph, Wolf, Elmar · 2024 · eLife
  37. Targeted protein degradation: therapeutic potential and challenges of PROTACs and molecular glues
    Sun Kim, Eui‐Bae Jeung · 2025 · Journal of Biomedical Translational Research
  38. A Glutathione S-Transferase Pi Molecular Glue Tethers Splicing Factors and Remodels Cell Metabolism
    David M. Leace, Madeleine L. Ware, Olivia L. Murtagh, Hsiao-Kuei Tsai, Chin‐Yuan Chang, Ku‐Lung Hsu · 2025 · Journal of the American Chemical Society
  39. Context matters: E3 ligase–ligand pairing strategies for optimized PROTAC performance
    Luyao Yin, Pengcheng Shu, Xiaozhong Peng · 2025 · Protein & Cell
  40. Discovery of SKP2‐Recruiting PROTACs for Target Protein Degradation
    Guanjun Dong, Aima Huang, Ziqing Zhao, Bikai Lai, Xin Pan, Huiyu Yang, Xiaohan Xu, Tianwei Wang, Fangchen Zhao, Zhimin Zhang et al. · 2026 · Advanced Science
  41. Small-molecule degraders for oncogenic KRASG12C and pan-KRAS mutations
    Jianxiong Deng, Shujun Shen, Lei Huang, Fang Xu, Weizhen Huang, Chaoming Huang, Zhang Zhang, Tongzheng Liu, Yi Tan, Zhengqiu Li · 2026 · Nature Communications
  42. The application of drug delivery systems based on targeted protein degradation chimeras in disease treatment strategies
    Weiqi Lin, Enqi Qiao, Zhongkai Wang, Chunqing Tang, Chenghui Li, Jin Lu · 2026 · Journal of Nanobiotechnology
  43. Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL)
    Simon C. C. Lucas, Yong Xu, Sarah H. Hewitt, Gavin W. Collie, Lucia Fusani, Ganesh Kadamur, Thomas E. Hadfield, Nancy Su, C. Truman, Sylvain Demanze et al. · 2025 · ACS Medicinal Chemistry Letters
  44. Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1
    Shiyang Zhai, Nicola Willemsen, Tao Sun, Mateo Malenica, Shixin Deng, Matthias Geyer, Finn K. Hansen · 2025 · ACS Medicinal Chemistry Letters
  45. Covalent Reprogramming of Kinase Binders to Modulate Protein Abundance
    Chen Mozes, Xiao-Kang Jin, Miguel A. Campos, Chen Zhou, Xiao-Yu Zhang · 2026 · Advancement of science
  46. New Reversible Covalent Warheads: Cyanobenzothiazoles Recruiting DCAF16 for Targeted Protein Degradation
    Jixian Zhang, Lei Huang, Shengrong Li, Yifang Li, Yi Tan, T Liu, Li Z · 2026 · Journal of Medicinal Chemistry
  47. DCAF11-dependent molecular glue degrader activated by glutathionylation
    Hojong Yoon, Franziska Wachter, Katharine Barrett, Cyrus Jin, Anna Rodríguez-Pöhnlein, Justine C. Rutter, Ryan J. Lumpkin, Rebecca J. Metivier, Katherine A. Donovan, Kheewoong Baek et al. · 2026 · Nature
  48. The PROTAC milestone: FDA approval of vepdegestrant (ARV-471) for ESR1-mutated breast cancer
    Xin Lin, Hua Xiang, Guoshun Luo · 2026 · Drug Discovery Today
  49. Covalency-enabled Drug Discovery is Redefining Druggability
    Jeffrey M. McKenna, Rupert S. J. Proctor · 2023 · CHIMIA International Journal for Chemistry
  50. Isolation and characterization of β-transducin repeat-containing protein ligands screened using a high-throughput screening system
    XINTONG LIU, Emiko Sanada, Jiang Li, Xiaomeng Li, Hiroyuki Osada, Nobumoto Watanabe · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  51. Insights and Future Perspectives of Covalent Protein Degraders
    Xiaoyu Zhang · 2022 · Wiley eBooks
  52. Making transient complexes stick
    YiYu Wang, M. S. S. Vinod Mouli, Min Ma, Fleur M. Ferguson · 2024 · Nature Chemical Biology
  53. Drug discovery technologies–Current and future trends
    Mark C. Noe, Claire M. Steppan, Andrea D. Weston · 2025 · Elsevier eBooks
  54. Proteome‐Wide Ligand and Target Discovery by Using β ‐Nitrostyrene Electrophiles: Supporting Targeted Protein Degradation
    Xinyao Ouyang, Xiaomeng Chai, Lei Huang, Yubin Chen, Shengrong Li, Weizhen Huang, Yi-Fang Li, Ke Ding, Tongzheng Liu, Yi Tan et al. · 2025 · Angewandte Chemie
  55. Chemical Proteomics Identifies RBBP7 as a New E3 Ligase Supporting Targeted Protein Degradation
    Yue Liu, Tao Yang, Lei Huang, Shengrong Li, Tongzheng Liu, Yi Tan, Zhengqiu Li · 2025 · Angewandte Chemie
  56. Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC Design
    Jinyi Liang, Yuyang Liu, Man Zhao, Lu Chen, Jiajie Qin, Wenjing Ma, Yue Wang, Haiqiang Wu, Ruilin Tian, Tianzi Wei et al. · 2026 · Journal of Medicinal Chemistry
  57. Harnessing reactive oxygen species for precision medicine: ROS-Activatable PROTACs for lung Cancer
    Manuel Olazábal-Morán, C. Blázquez-Barbadillo, E. Pérez-Izquierdo, M. Muñoz-Silva, A. Garrido · 2026 · Advanced Drug Delivery Reviews
  58. Targeted proteoform degradation for precision drug design, delivery, and therapy
    Chen-Yu Cui, Hao-Yue Zhang, Xinmiao Wang, Na Li, Xian-Quan Zhan · 2026 · Drug Delivery
  59. Covalent Molecular Glues: Mechanisms, Design Principles, and Emerging Therapeutic Opportunities in Targeted Protein Degradation
    Ahmed Ali Al-Karmalawy, Mohamed Ibrahim Attia, Tarek A. Yousef, Mohammed Bashar Al-Qazzan, Mohammed Al-Akeedi, Arwa Omar Al Khatib, Samia S. Hawas · 2026 · Archiv der Pharmazie
  60. Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
    Rufeng Fan, Jiahui Ni, Tiantian Zhou, H Q Jiang, Wensi Zhao, Minjia Tan · 2026 · Angewandte Chemie International Edition
  61. RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1
    Chang Shen, HD Sun, Ruining Li, Raghupathi Mutyala, Xinjian Tian, Chaoqun Huang, Jinglei Hu, Jie An, Lin Li, Tao Zhang et al. · 2026 · Journal of Medicinal Chemistry
  62. An optimized RNF126-targeting covalent handle for molecular glue degraders
    Aman Modi, Ethan S. Toriki, Christian E. Stieger, Emily A. Lau, Claire Song, Alyssa J. Chew, Amy C. Tsao, Kaila Nishikawa, Jeffrey M. McKenna, Daniel K. Nomura · 2026 · Bioorganic & Medicinal Chemistry Letters
  63. Novel Technologies in PROTAC Design
    Keerti Jain, Sukuru Chinna Reddy, Sreevardhan Moode, Piyush Mehra, Sofiya Tarannum, Manisha Patel, Vineet Kumar Jain, Harvinder Popli · 2024 · Springer eBooks
  64. Covalent Bifunctional Molecules (CBMs): Achievements and Challenges
    Yuting Xin, Fangsu Chen, Qidong You, Lei Wang, Qiuyue Zhang · 2025 · Medicinal Research Reviews
  65. Discovery of Alkenyl Oxindole as a Novel PROTAC Moiety for Targeted Protein Degradation via CRL4 DCAF11 Recruitment
    Ying Wanga, Tianzi Wei, Man Zhao, Aima Huang, Fan Sun, Lu Chen, Risheng Lin, Yubao Xie, Ming Zhang, Shiyu Xu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Identification of clofibric acid as a SYVN1 ligand for PROTAC development
    Warren, Julia, MD, PhD, Anandarao Munakala, Keith D. Zientek, Kilsun Kim, Phillip A. Wilmarth, Ashok P. Reddy, Bingbing X. Li, Xiangshu Xiao · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Chemistry of Covalent Drugs: Chemical Reactions with Endogenous Proteins in Live Cells
    Naoya Shindo, Akio Ojida · 2024 · Journal of Synthetic Organic Chemistry Japan
  68. Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
    Bikash Adhikari, Katharina Schneider, Mathias Diebold, Christoph Sotriffer, Elmar Wolf · 2024 · eLife
  69. eLife Assessment: Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
    Agnieszka Chacińska · 2024 · eLife
  70. Reviewer #1 (Public Review): Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
    Bikash Adhikari, Katharina Schneider, Mathias Diebold · 2024 · eLife
  71. Reviewer #2 (Public Review): Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
    Bikash Adhikari, Katharina Schneider, Mathias Diebold · 2024 · eLife
  72. Covalency in PROTACs: Mechanisms and applications
    Thomas M. Geiger, Radosław P. Nowak · 2024 · Annual reports in medicinal chemistry
  73. Identification of Suitable Target/E3 Ligase Pairs for PROTAC Development using a Rapamycin-induced Proximity Assay (RiPA)
    Bikash Adhikari, Katharina Schneider, Mathias Diebold, Christoph Sotriffer, Elmar Wolf · 2024 · eLife
  74. PROTACS- targeted protein degradation as a path to precision cancer therapeutics
    Hannah R Gatley, Paul B. Fisher, Swadesh Kumar Das · 2025 · Advances in cancer research
  75. Covalent Reprogramming of Kinase Binders to Modulate Protein Homeostasis
    Chen Mozes, Xiao‐Kang Jin, Miguel A. Lorenzo Campos, Chen Zhou, Xiaoyu Zhang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Dual Target E3 Ligase Ligands: A New Way to Overcome Drug Resistance
    相奕 潘 · 2026 · Hans Journal of Medicinal Chemistry
  77. Scalable insect cell expression and purification screening applied to CRL4-DCAF substrate receptors
    2026
  78. An interactome-based framework for DDB1- and CUL4-associated factor prioritization in targeted protein degradation
    Satoshi Yamanaka, Koya Nagaoka, Yuki Shoya, Kohei Nishino, Yumi Mikura, Kenshi Tanaka, Keisuke Konishi, Yoshinori Hasegawa, Atsushi Hijikata, Hidetaka Kosako et al. · 2026 · Molecular Cell
  79. Design and synthesis of trisubstituted 1,2,4-triazoles : structural exploration in the inhibition of GSK-3β for the treatment of Alzheimer’s disease
    Thiago M. Pereira · 2024 · theses.fr (ABES)
  80. DNA‐Encoded Libraries for the Discovery of E3 Ligase Ligands
    Lulu Wen, Qingqing Zhang, Zhiqiang Duan, Rui Jin, Xiaojie Lu · 2026 · ChemMedChem
  81. Targeted protein degradation in the digital era: Computational challenges and opportunities for PROTACs
    Aishani Tewari, Aiswarya B. Pawar, Sudip Roy · 2026 · In Silico Research in Biomedicine
  82. Identification of Clofibric Acid as a Synoviolin (SYVN1) Ligand for Proteolysis-Targeting Chimera (PROTAC) Development
    Warren, Julia, MD, PhD, Anandarao Munakala, Keith D. Zientek, Kilsun Kim, Phillip A. Wilmarth, Ashok P. Reddy, Bingbing X. Li, Xiangshu Xiao · 2026 · ACS Medicinal Chemistry Letters
  83. Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
    Rufeng Fan, Jiahui Ni, Tiantian Zhou, H Q Jiang, Weidong Zhao, Minjia Tan · 2026 · Angewandte Chemie
  84. Persistence of the coral Porites harrisoni in the Persian/Arabian Gulf is underpinned by strong selection on few genomic loci
    Anna Fiesinger, Rachel Alderdice, Luigi Colin, Gabriela Perna, Hannah Manns, Samantha Goyen, Line Kolind Bay, Nitin S. Baliga, Jacob J. Valenzuela, Daniel J. Barshis et al. · 2026 · Research Square
  85. Discovery of DCAF16-based PROTACs as SHP2 degraders
    Xiaojing Pang, Yuxin Gan, Qingyuan Hu, Wenshuo Zheng, Yang Liu, Kexin Zhang, Yueying Yang, Lixia Chen, Hua Li · 2026 · Bioorganic Chemistry
  86. Chemically Induced Proximity in Biological Modulation
    Xiaokang Jin, Chen Zhou, Xiaoyu Zhang · 2026 · ACS Bio & Med Chem Au
  87. Fitness criteria for PROTACs as chemical probes: principles and applications
    Manon Sturbaut, Alessio Ciulli · 2026 · Essays in Biochemistry
  88. Covalent Recruitment of E3 Ligases: A New Path for Rational Design of Protein Degraders
    Ziyan Yu, Jianqiang Zhang, Man Tong, Lanlan Zang, Jie Sun, Xiaoyun Lu · 2026 · Medicinal Research Reviews
  89. BindingDB Entry 50021193: Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update.
    BindingDB · 2025 · UC San Diego
  90. BindingDB Entry 50022940: Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders.
    BindingDB · 2026 · UC San Diego
  91. BindingDB Entry 50021782: Expanding the ligand spaces for E3 ligases for the design of protein degraders.
    BindingDB · 2025 · UC San Diego
  92. BindingDB Entry 50019485: Recent advances in the development of EGFR degraders: PROTACs and LYTACs.
    BindingDB · 2024 · UC San Diego
  93. BindingDB Entry 50023187: Recent advances in developing targeted protein degraders.
    BindingDB · 2026 · UC San Diego
  94. BindingDB Entry 50023013: A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins.
    BindingDB · 2026 · UC San Diego
  95. BindingDB Entry 50022313: Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs.
    BindingDB · 2025 · UC San Diego
  96. BindingDB Entry 50020357: Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches.
    BindingDB · 2024 · UC San Diego
  97. BindingDB Entry 50016429: Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond.
    BindingDB · 2023 · UC San Diego
  98. BindingDB Entry 50018114: Homobivalent, Trivalent, and Covalent PROTACs: Emerging Strategies for Protein Degradation.
    BindingDB · 2024 · UC San Diego
  99. BindingDB Entry 50019665: E3 Ligases Meet Their Match: Fragment-Based Approaches to Discover New E3 Ligands and to Unravel E3 Biology.
    BindingDB · 2024 · UC San Diego
  100. BindingDB Entry 50020409: Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design.
    BindingDB · 2024 · UC San Diego